Interruption of Antiretroviral Therapy Initiated during Primary HIV-1 Infection: Impact of a Therapeutic Vaccination Strategy Combined with Interleukin (IL)-2 Compared with IL-2 Alone in the ANRS 095 Randomized Study-Reference-Cited by-同舟云学术

Interruption of Antiretroviral Therapy Initiated during Primary HIV-1 Infection: Impact of a Therapeutic Vaccination Strategy Combined with Interleukin (IL)-2 Compared with IL-2 Alone in the ANRS 095 Randomized Study

Published:2007-09 Issue:9 Volume:23 Page:1105-1113
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Goujard Cécile¹²,Marcellin Fabienne³,Hendel-Chavez Houria²⁴,Burgard Marianne⁵,Meiffrédy Vincent³,Venet Alain²,Rouzioux Christine⁵,Taoufik Yacine²⁴,El Habib Raphaëlle⁶,Beumont-Mauviel Maria⁷,Aboulker Jean-Pierre³,Lévy Yves⁸,Delfraissy Jean-François¹²,

Affiliation:

1. Service de Médecine Interne, Bicêtre Hospital, AP-HP, Le Kremlin Bicêtre, Paris, France.

2. INSERM U802, Faculté de Médecine Paris-Sud, Le Kremlin Bicêtre, Paris, France.

3. INSERM SC10, Villejuif, France.

4. Laboratoire d'Immunologie, Bicêtre Hospital, AP-HP, Le Kremlin Bicêtre, Paris, France.

5. Laboratoire de Virologie and EA-MRT 3620, Necker-Enfants Malades Hospital, AP-HP, Paris, France.

6. Sanofi Pasteur, Marcy l'Etoile, France.

7. Chiron, Suresnes, France. 8 Unité d'Immunologie Clinique, Mondor Hospital, AP-HP, Créteil, France.

8. Unité d'Immunologie Clinique, Mondor Hospital, AP-HP, Créteil, France.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2007.0047

Reference44 articles.

1. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

2. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

3. Dynamics of T Cell Responses in HIV Infection

4. HIV preferentially infects HIV-specific CD4+ T cells

5. Immune control of HIV-1 after early treatment of acute infection

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant physiochemistry and advanced nanotechnology for vaccine development;Chemical Society Reviews;2023

2. A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial;Journal of Virology;2021-04-12

3. Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response;Vaccines;2020-08-05

4. Clinical trials of antiretroviral treatment interruption in HIV-infected individuals;AIDS;2019-04-01

5. A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection;Science Translational Medicine;2017-12-06